Dr. Mouhammed Kelta, MD

Dr. Kelta practices at Affiliated Oncologists in Chicago Ridge, Illinois.

Dr. Kelta's NPI, 1649633918, was assigned on April 3, 2016. Dr. Kelta graduated from University of Aleppo Faculty of Medicine in 1986. Dr. Kelta holds Illinois license 036087250.

Dr. Kelta's primary practice is Affiliated Oncologists, at 10604 Southwest Hwy, Chicago Ridge, IL 60415 in Cook County. The practice phone is (310) 335-4000.

Dr. Kelta's primary practice is Affiliated Oncologists in Chicago Ridge, Illinois. Dr. Kelta is also affiliated with Advocate Christ Medical Center. The medical group on file is Affiliated Oncologists. Dmand AI also links Dr. Kelta to 3 more hospitals, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kelta practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kelta's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kelta is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Kelta's licenses on file in 2 states: Illinois and Wisconsin.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lymphoma and multiple myeloma among the conditions Dr. Kelta treats.

CMS data shows 1,229 Medicare services from Dr. Kelta across 13 procedure codes in 2024, for 281 Medicare patients. Medicare paid $80,515 for them.

CMS counts 281 Medicare patients who saw Dr. Kelta in 2024. The largest group is 65 to 74, with 111 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 3.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kelta's median patient age at 71, with 55% women.

In 2024, Dr. Kelta wrote 522 Medicare Part D claims for 76 patients. 76% of them were for generic drugs. CMS names the drug for 381 of them, across 17 drugs with 11 or more claims each, at $740,169 in total drug cost. In 2023, CMS named 457 claims across 21 drugs.

Dr. Kelta accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Kelta, published from 2015 to 2018. 2015 was the busiest year, with 2. The most frequent topics are Hodgkin Disease.

CMS Open Payments shows 183 general payments to Dr. Kelta from 49 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 88% of the total. Incyte Corporation paid the most, $402.

Dr. Kelta graduated from University of Aleppo Faculty of Medicine in 1986.

Dr. Kelta is in network with 19 carriers, including Aetna, Elevance and HCSC. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.